| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |